Accessibility Menu

Analyst: Bed Bath & Beyond Has a 32% Downside as COVID-19 "Nesting" Tapers Off

The firm is positive about Bed Bath & Beyond but thinks it's overvalued.

By Rhian Hunt Feb 1, 2021 at 2:14PM EST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.